Deerfield Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,060
| Closed | -$158K | – | 560 |
|
|
2024
Q1 | $158K | Buy |
24,060
+6,770
| +39% | +$44.4K | ﹤0.01% | 348 |
|
|
2023
Q4 | $112K | Buy |
+17,290
| New | +$112K | ﹤0.01% | 206 |
|
|
2023
Q3 | – | Sell |
-1,898,743
| Closed | -$16.6M | – | 105 |
|
|
2023
Q2 | $16.6M | Sell |
1,898,743
-160,678
| -8% | -$1.41M | 0.35% | 53 |
|
|
2023
Q1 | $24.4M | Sell |
2,059,421
-791,866
| -28% | -$9.38M | 0.54% | 48 |
|
|
2022
Q4 | $29M | Buy |
2,851,287
+991,287
| +53% | +$10.1M | 0.6% | 50 |
|
|
2022
Q3 | $11M | Buy |
+1,860,000
| New | +$11M | 0.22% | 79 |
|
|
2022
Q2 | – | Sell |
-2,345,959
| Closed | -$6.97M | – | 134 |
|
|
2022
Q1 | $6.97M | Hold |
2,345,959
| – | – | 0.16% | 81 |
|
|
2021
Q4 | $16.6M | Hold |
2,345,959
| – | – | 0.35% | 64 |
|
|
2021
Q3 | $24.4M | Hold |
2,345,959
| – | – | 0.48% | 59 |
|
|
2021
Q2 | $28.8M | Hold |
2,345,959
| – | – | 0.51% | 60 |
|
|
2021
Q1 | $51.6M | Buy |
+2,345,959
| New | +$51.6M | 1.08% | 27 |
|